ARTICLE | Clinical News
Antibe Therapeutics preclinical data
March 14, 2016 7:00 AM UTC
In mice with a genetic predisposition to intestinal cancer, once-daily ATB-346 for 2 weeks completely prevented the formation of intestinal polyps. In mice that had already developed polyps in the col...